In the News

Recent Coverage of HMS in the News
July 5, 2012

An interview with John Halamka, CIO for Beth Israel Deaconess Medical Center, explores his argument for why health information exchanges should use an “opt-in to disclose” policy to safeguard patient data.

July 5, 2012

Studying the stem cells of people with Parkinson's disease can help point to better treatments, according to a study led by Ole Isacson, HMS professor of neurology at McLean Hospital. A portion of the research involved reprogramming patients' skin cells into neurons — cells specific to the nervous system that are destroyed by Parkinson's — and examining the neurons under different conditions.

July 4, 2012

The delirium that sometimes follows surgery may leave older heart patients with lingering problems with their mental function, including memory and attention, according to research from Hebrew SeniorLife, Beth Israel Deaconess Medical Center and Harvard Medical School.

July 4, 2012

Neighboring non-cancer cells may contribute to drug resistancesresist drug treatment, researchers report in Nature. Todd Golub and Levi Garraway of HMS, the Broad Institute and Dana Farber Cancer Institute; Ravid Straussman of the Broad; and Keith Flaherty of HMS and Massachusetts General Hospital are quoted.

July 3, 2012

A biotech company in Cambridge called Genocea believes it can create the first effective T-cell vaccines. Darren Higgins, HMS professor of microbiology and immunobiology, is a cofounder of Genocea.

July 3, 2012

A new health services business is looking to catch what its founder sees as an emerging third wave in the clinical application of genomics. Mark S. Boguski, HMS associate professor of pathology at the Center for Biomedical Informatics, is quoted.

July 3, 2012

Nearly two-thirds of American teenagers admit to having "anger attacks" that involve destroying property, threatening or engaging in violence, a new study found. And one in 12 has intermittent explosive disorder, characterized by chronic, uncontrollable fits of rage. Ronald Kessler, the McNeil Family Professor of Health Care Policy at HMS, is the lead author of the study.

July 2, 2012

Drinking more caffeinated coffee may help to lower the risk of developing basal cell carcinoma, the most common form of skin cancer, according to a new study. Jiali Han, HMS associate professor of dermatology at Brigham and Women’s Hospital, is the lead author of the paper.

Pages

Submit Photo Requests to HMS
To request photos from the HMS Office of Communications and External Relations, click here.

 

Tell us about your awards
Share news of your achievements with the larger HMS community.  Click here.

 

Book Reviews
If you are a faculty member who has published a book recently, click here.